BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) 

75 Sidney Street, 4th Floor

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-299-5000 Fax: 617-995-4995


SEARCH JOBS

View Clinical Trials from BioPharm Insight



 Key Statistics


Email: info@aveopharma.com
Ownership: Public

Web Site: AVEO Oncology
Employees:
Symbol: AVEO
 





Collaborations

Merck & Co.  Cancer





 Company News
AVEO Oncology (AVEO) To Host Conference Call To Discuss Presentation Of Final Results And Biomarker Analysis From Phase 2 Study Of Tivozanib In Patients With Advanced Colorectal Cancer 2/27/2015 10:53:27 AM
AVEO Oncology (AVEO) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/12/2015 10:25:03 AM
AVEO Oncology (AVEO) Names Michael N. Needle, M.D., As Chief Medical Officer 1/9/2015 9:42:52 AM
AVEO Oncology (AVEO) Receives Confirmation Of Eligibility For Submission Of A Tivozanib Marketing Authorization Application To European Medicines Agency 1/8/2015 11:35:41 AM
Cambridge's AVEO Oncology (AVEO) Chops Two-Thirds of Workforce 1/7/2015 6:17:14 AM
AVEO Oncology (AVEO)'s Comeback Hits a Snag as Nasdaq Warns It Could be Delisted 12/31/2014 6:10:34 AM
AVEO Oncology (AVEO), Ophthotech Corporation (OPHT) Forge Research, License Deal Worth $105 Million+ 11/11/2014 7:03:37 AM
AVEO Oncology (AVEO) Reports Third Quarter 2014 Financial Results 11/6/2014 11:00:00 AM
AVEO Oncology (AVEO) And Biodesix, Inc. Announce Exploratory Analysis Of Veristrat-Selected Patients With Non-Small Cell Lung Cancer In Phase 2 Study Of Ficlatuzumab Presented At ESMO 2014 Congress 9/29/2014 12:17:49 PM
AVEO Oncology (AVEO) Announces Results From Phase 2 Clinical Studies Of Tivozanib In Patients With Advanced Colorectal And Kidney Cancers Presented At ESMO 2014 Congress 9/29/2014 11:37:32 AM
12345678910...